Cohen Veterans Bioscience

CVB Recommends a Prioritization of Research for the White House Suicide Prevention Plan
November 10, 2021
We encourage the administration to leverage interagency collaboration and public-private partnerships with those in the research community, so the benefits of new and existing research into the invisible wounds can be maximized more quickly.
Read more
Q&A with Dallas Hack, MD (Colonel, U.S. Army, Retired), Veterans Science Strategy Advisor
November 9, 2021
Dr. Dallas Hack, a medical doctor and Veteran, has been involved with CVB almost since its beginning, in 2015. He brings to his role on our Strategic Advisory Council his deep expertise in medical research and in organizational leadership. We spoke to him recently about his experiences in the military, as well as his thoughts on CVB, in particular, the Brain Trauma Blueprint, in which he has been deeply involved.
Read more
Traumatic Brain Injury: Strategies for Implementing Diagnosis and Treatment Guidelines
November 4, 2021
Published in the Journal of Neurotrauma, the article reviews factors that impact adoption and implementation of best practices for the management of traumatic brain injury (TBI). It also examines enablers of implementation and strategies for mitigating the barriers to optimal uptake.
Read more
Q&A with Katrina Wolf, First Responder and Brain Health Advocate
October 26, 2021
As a resiliency officer in a jail, Katrina Wolf is closely attuned to the mental health issues of her fellow corrections officers. We spoke with Katrina about her work as a resiliency officer, as well as about her own history with trauma and C-PTSD.
Read more
Best Negative Data Prize Awarded to Dr. Chadi G. Abdallah
October 4, 2021
Cohen Veterans Bioscience and the European College of Neuropsychopharmacology (ECNP) have awarded the 2021 Best Negative Data Prize in Clinical Neuroscience to Chadi Abdallah, MD whose work inadvertently revealed mechanisms that may play a role in depression relapse following treatment with ketamine.
Read more